Report Categories Report Categories

Report Categories

industry Category

All

Total: 2 records, 1 pages

Global Adalimumab (Humira) and Biosimilar Supply, Demand and Key Producers, 2023-2029

date 22 May 2023

date Pharma & Healthcare

new_biaoQian Adalimumab (Humira) and Biosimilar

The global Adalimumab (Humira) and Biosimilar market size is expected to reach $ 16210 million by 2029, rising at a market growth of -4.9% CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Adalimumab (Humira) and Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 22 May 2023

date Pharma & Healthcare

new_biaoQian Adalimumab (Humira) and Biosimilar

According to our (Global Info Research) latest study, the global Adalimumab (Humira) and Biosimilar market size was valued at USD 23070 million in 2022 and is forecast to a readjusted size of USD 16210 million by 2029 with a CAGR of -4.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

Add To Cart

Add To Cart

industry 22 May 2023

industry Pharma & Healthcare

new_biaoQian Adalimumab (Humira) and Biosimilar

The global Adalimumab (Humira) and Biosimilar market size is expected to reach $ 16210 million by 2029, rising at a market growth of -4.9% CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 22 May 2023

industry Pharma & Healthcare

new_biaoQian Adalimumab (Humira) and Biosimilar

According to our (Global Info Research) latest study, the global Adalimumab (Humira) and Biosimilar market size was valued at USD 23070 million in 2022 and is forecast to a readjusted size of USD 16210 million by 2029 with a CAGR of -4.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

addToCart

Add To Cart